3 Results for "

gdc-6036

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "gdc-6036" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-145928
CAS No.: 2417987-45-0
Purity:  99.31%
Synonyms: gdc-6036
Target:  

Ras

Research Areas:  

Cancer

Divarasib (GDC-6036) is an orally active, selective KRAS G12C inhibitor with an IC50 of <0.01 μM. Divarasib covalently binds Cys12 in GDP-bound KRAS G12C, occupies the switch II pocket, blocks GTP binding and SOS-mediated reactivation, and inhibits oncogenic KRAS signaling. Divarasib induces tumor shrinkage and robust tumor growth inhibition in KRAS G12C-positive models and cancer cells. Divarasib can be used for the research of non-small cell lung cancer, colorectal adenocarcinoma, pancreatic ductal adenocarcinoma, and other KRAS G12C-mutated solid tumors .
6
6 Cited Publications
Cat. No.: HY-145928B
CAS No.: 2762240-36-6
Synonyms: gdc-6036 adipate
Target:  

Ras

Research Areas:  

Cancer

Divarasib (GDC-6036) adipate is an orally active, selective KRASG12C inhibitor with an IC50 of <0.01 μM. Divarasib adipate covalently binds Cys12 in GDP-bound KRASG12C, occupies the switch II pocket, blocks GTP binding and SOS-mediated reactivation, and inhibits oncogenic KRAS signaling. Divarasib adipate induces tumor shrinkage and robust tumor growth inhibition in KRASG12C-positive models and cancer cells. Divarasib adipate can be used for the research of non-small cell lung cancer, colorectal adenocarcinoma, pancreatic ductal adenocarcinoma, and other KRASG12C-mutated solid tumors .
Cat. No.: HY-147229
CAS No.: 2417918-80-8
Purity:  98.06%
Target:  

Ras

Research Areas:  

Cancer

GDC-6036-NH is from patent WO2020097537A2, and a precursor of compound 17 a/b. Compound 17 a/b is a RAS inhibitor and can be used in cancer research .